Janus Henderson Group plc 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:34 am Sale |
2024-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-4,809,518 (Position Closed) |
Filing |
| 2024-11-14 12:28 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
4,809,518 6.200% |
651,408 (+15.67%) |
Filing |
| 2024-05-22 4:06 pm Purchase |
2024-05-13 | 13G | CytomX Therapeutics, Inc. CTMX |
JANUS HENDERSON GROUP PLC JHG |
4,158,110 5.300% |
4,158,110 (New Position) |
Filing |